IL6 and Alzheimer disease: This is supported by studies associating genetic polymorphisms in various inflammation-associated genes with AD risk, including polymorphisms in triggering receptor expressed on myeloid cell (TREM) 2, cluster of differentiation (CD) 33, IL-6, toll-like receptor (TLR) 4, and IL-1 [11–17].